;){kind=logo}
About
AION Labs is a first-of-its-kind alliance of global pharma and technology leaders and investors that have come together with one clear mission: to create and adopt gateway AI and computational technologies that will transform the process of drug discovery and development for the betterment of human health.
We invite brilliant inventors, scientists and technologists to solve the biggest R&D challenges of today’s pharma with the support and guidance of years of accumulated know-how, data, and experience of our partners.
Backed by our partners’ wealth of knowledge and fresh multidisciplinary approach, we combine the ingenuity, agility and innovative instinct of Israel’s start-up ecosystem to create and develop strong companies with disruptive technology which will pave the way to the future of pharma.
Our unique venture creation process eliminates the gap between technologies and markets with our built in product-market innovation model.
Challenges
Challenge #01
Challenge #02
Challenge #03
Antibodies for Targeted Therapies
Challenge #04
Challenge #5
Challenge #6
Partners
Latest news
Fierce Biotech: Pfizer, AstraZeneca, Merck KGaA-backed Israeli AI incubator launches first biopharma startup
Q&A: AION Labs' new startup aims to streamline the drug discovery process
AIThority: AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies
AION Labs Launches Second Global Call for Application: Artificial Intelligence for Clinical Trial Readiness of Drug Candidates
AION Labs Launches First Global Call for Application: Artificial Intelligence for Antibody Design
A partnership between six leading tech and pharma companies wants to create and adopt new AI technologies that could transform the process of drug discovery and development.
AWS joins pharma and biotech leaders in launching AION Labs to transform therapeutics
Pfizer Pharmaceutical, AstraZeneca and Amazon to Build New Innovation Laboratory in Israel
AION Labs committed to industry best practices business ethics and compliance of IFPMA
Pharma Leaders companies join hands with Amazon on new Israel-based AI Innovation Lab
Call for Application:
AION Labs spots 'unique opportunity' for AI-driven antibody discovery
AION Labs Launches Second Global Call for Application: Artificial Intelligence for Clinical Trial Readiness of Drug Candidates
Executives Discuss AION Labs, a First-of-its-Kind Innovation Lab Focused on AI Technologies
AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies
Interview with AION Labs CTO: How AL/ML are transforming drug discovery and development
Outsourcing Pharma: AION Labs creates AI startup to increase success of drug candidates
Israel lab backed by pharma giants mints startup for computer-designed antibodies
Contact us
AION Labs | info@aionlabs.com | www.aionlabs.com | Connect with us on
AION Labs
info@aionlabs.com | Connect with us